As of 2025-07-15, the Relative Valuation of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is (125.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.19 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd based on Relative Valuation is -983.1%.
The range of the Relative Valuation is (123.92) - (169.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 19.5x | 14.6x |
| Forward P/E multiples | 13.6x - 21.6x | 14.2x |
| Fair Price | (123.92) - (169.87) | (125.31) |
| Upside | -973.3% - -1297.1% | -983.1% |
| Date | P/E |
| 2025-07-14 | -1.63 |
| 2025-07-11 | -1.60 |
| 2025-07-10 | -1.73 |
| 2025-07-09 | -1.66 |
| 2025-07-08 | -1.60 |
| 2025-07-07 | -1.58 |
| 2025-07-03 | -1.68 |
| 2025-07-02 | -1.70 |
| 2025-07-01 | -1.60 |
| 2025-06-30 | -1.62 |
| 2025-06-27 | -1.62 |
| 2025-06-26 | -1.69 |
| 2025-06-25 | -1.65 |
| 2025-06-24 | -1.70 |
| 2025-06-23 | -1.66 |
| 2025-06-20 | -1.66 |
| 2025-06-18 | -1.65 |
| 2025-06-17 | -1.67 |
| 2025-06-16 | -1.74 |
| 2025-06-13 | -1.78 |
| 2025-06-12 | -1.79 |
| 2025-06-11 | -1.80 |
| 2025-06-10 | -1.93 |
| 2025-06-09 | -1.96 |
| 2025-06-06 | -1.96 |
| 2025-06-05 | -1.86 |
| 2025-06-04 | -1.86 |
| 2025-06-03 | -1.81 |
| 2025-06-02 | -1.80 |
| 2025-05-30 | -1.70 |
| 2025-05-29 | -1.69 |
| 2025-05-28 | -1.73 |
| 2025-05-27 | -1.76 |
| 2025-05-23 | -1.80 |
| 2025-05-22 | -1.77 |
| 2025-05-21 | -1.80 |
| 2025-05-20 | -1.87 |
| 2025-05-19 | -1.81 |
| 2025-05-16 | -1.84 |
| 2025-05-15 | -1.82 |
| 2025-05-14 | -2.26 |
| 2025-05-13 | -2.24 |
| 2025-05-12 | -2.36 |
| 2025-05-09 | -2.33 |
| 2025-05-08 | -2.33 |
| 2025-05-07 | -2.19 |
| 2025-05-06 | -2.20 |
| 2025-05-05 | -2.60 |
| 2025-05-02 | -2.63 |
| 2025-05-01 | -2.58 |